SEC filings · updated every 10 minutes
At the SEC on Tuesday, November 10
Tuesday, November 10, 2026 · 226 filings · latest: 21:47 ET
From the companies the site's managers follow: those held by 300+ 13F filers, or 30+ with concentrated managers or well-known investors. Form 144 notices from $1M and insider purchases from $100,000.
Companies with the most concentrated managers that filed that day
Filings of the day
226 filings from 213 companies
HF Sinclair
DINO- 21:47 ET5%+ stakesSEC Schedule 13D/A
Change in a 5%+ stake with activist intent
REH Advisors reports a 2.7% stake (4,431,662 shares), below 5% as of October 29, 2026.
Filed by: REH Advisors Inc.
On GestorLens
- 4 concentrated managers
- 450 13F filers
- 2 insiders bought in 180 days ($3.5M)
- 1 13D filings in the last year
Well-known investors: Semper Augustus
GestorLens profileWolfspeed
WOLF- 19:57 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
the Goldman Sachs Group and 1 related filer updated their stake: 5.3% (2,810,829 shares) (passive, 13G) as of September 30, 2026.
Filed by: GOLDMAN SACHS GROUP INC
On GestorLens
- 1 concentrated managers (+1 this quarter)
- 86 13F filers
Well-known investors: Dan Loeb
GestorLens profileUWM Holdings
UWMC- 19:53 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
the Goldman Sachs Group and 1 related filer report a 2.6% stake (9,081,465 shares), below 5% as of September 30, 2026.
Filed by: GOLDMAN SACHS GROUP INC
On GestorLens
- 133 13F filers
- 1 13D filings in the last year
Well-known investors: Stanley Druckenmiller
GestorLens profileLiberty Global
LBTYK- 19:42 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
the Goldman Sachs Group and 1 related filer reported a stake: 6.3% (11,214,077 shares) (passive, 13G) as of September 30, 2026.
Filed by: GOLDMAN SACHS GROUP INC
On GestorLens
- 1 concentrated managers
- 128 13F filers
Well-known investors: Seth Klarman
GestorLens profileIREN
IREN- 19:35 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
the Goldman Sachs Group and 1 related filer updated their stake: 7.2% (28,444,392 shares) (passive, 13G) as of September 30, 2026.
Filed by: GOLDMAN SACHS GROUP INC
On GestorLens
- 3 concentrated managers
- 332 13F filers
Well-known investors: Stanley Druckenmiller
GestorLens profileBlack Stone Minerals
BSM- 17:16 ETInsider buyingSEC Form 4 (P)
Open-market purchase by an insider
Thomas L Carter Jr (Executive Chairman) bought 50,000 shares for $686,290 (avg. $13.73).
On GestorLens
- 3 concentrated managers
- 116 13F filers
- 2 insiders bought in 180 days ($2.2M)
nVent Electric
NVT- 17:16 ETInsider buyingSEC Form 4 (P)
Open-market purchase by an insider
Herbert K Parker (director) bought 3,000 shares for $339,435 (avg. $113.15).
Illumina
ILMN- 17:15 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Corvex Management may sell up to 375,000 shares (~$82.8 million, 0.25% of shares outstanding) on or about November 10, 2026.
Graco
GGG- 17:13 ETDividends and buybacksSEC 8-K 8.01
Share buyback
New share buyback of up to 15,000,000 shares.
Company headline: “Graco Announces $600 Million Accelerated Share Repurchase Agreement”
Also: Regulation FD disclosure
From the filing
In December 2025, the Company's Board of Directors (the "Board") authorized the Company's repurchase of up to an aggregate of 15 million shares of Common Stock, which was in addition to the approximately 8 million shares of Common Stock remaining under the share repurchase authorization approved by the Board in December 2018.
Textron
TXT- 17:12 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Invesco reported a stake: 5.1% (8,853,800 shares) (passive, 13G) as of September 30, 2026.
Filed by: Invesco Ltd.
Centrus Energy
LEU2 filings- 17:04 ETLeadership changesSEC 8-K 5.02
Departure or appointment of directors or officers
Kevin M. Graney joins the board.
From the filing
On November 4, 2026, the Board of Directors (the “Board”) of Centrus Energy Corp. (the “Company”) increased its size from seven directors to eight directors and appointed Kevin M. Graney to the Board effective immediately.
- 06:50 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street and 1 related filer reported a stake: 7.4% (1,468,760 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Neurocrine Biosciences
NBIX- 16:47 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Sanjay Keswani may sell up to 53,614 shares (~$9.0 million, 0.05% of shares outstanding) on or about November 10, 2026.
Monolithic Power Systems
MPWR- 16:47 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Invesco reports a 4.8% stake (2,354,421 shares), below 5% as of September 30, 2026.
Filed by: Invesco Ltd.
MKS
MKSI- 16:46 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Invesco reports a 3.5% stake (2,382,533 shares), below 5% as of September 30, 2026.
Filed by: Invesco Ltd.
Vivmark Residential
VMRK- 16:44 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Barry Altshuler (officer) may sell up to 49,808 shares (~$3.3 million) on or about November 10, 2026.
Manhattan Associates
MANH- 16:42 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Invesco reported a stake: 5.7% (3,325,462 shares) (passive, 13G) as of September 30, 2026.
Filed by: Invesco Ltd.
On GestorLens
- 2 concentrated managers
- 284 13F filers
Well-known investors: Terry Smith
GestorLens profileFedEx
FDX- 16:38 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Claude F Russ (officer) may sell up to 16,762 shares (~$5.3 million) on or about November 10, 2026.
On GestorLens
- 9 concentrated managers
- 1,155 13F filers
Well-known investors: Gates Foundation Trust, Viking Global
GestorLens profileMotorola Solutions
MSI- 16:38 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Gregory Q Brown (officer, director) may sell up to 25,000 shares (~$13.2 million) on or about November 10, 2026.
Paychex
PAYX- 16:33 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: B Thomas Golisano (10% holder) may sell up to 439,970 shares (~$51 million, 0.12% of shares outstanding) on or about November 9, 2026.
On GestorLens
- 15 concentrated managers
- 963 13F filers
Well-known investors: Markel Group, Semper Augustus
GestorLens profileCarvana
CVNA- 16:32 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: James Danforth Quayle (director) may sell up to 27,655 shares (~$2.0 million) on or about November 10, 2026.
On GestorLens
- 3 concentrated managers (+1 this quarter)
- 404 13F filers
- 1 insider bought in 180 days ($2,207)
- 1 13D filings in the last year
Well-known investors: Lone Pine, Viking Global, Coatue, Stanley Druckenmiller
GestorLens profileFirstService
FSV- 16:32 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Fred Reichheld (director) may sell up to 7,200 shares (~$1.1 million) on or about November 10, 2026.
Alcon
ALC- 16:31 ETEarningsSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “Innovation and Product Launch Momentum Drive Alcon’s Third-Quarter 2026 Growth”
From the company's release
"We remain on track for our 2026 objectives with year-to-date sales growth of six percent and double-digit core EPS growth, despite some specific areas of competitive pressure.” said David J. Endicott, Alcon’s Chief Executive Officer.
Elevance Health
ELV- 16:30 ETOtherSEC 8-K 7.01
Regulation FD disclosure
From the filing
Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts this week. During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year 2026 to be at least $22.00 per diluted share, including approximately $7.00 per diluted share of net unfavorable items.
On GestorLens
- 14 concentrated managers (-3 this quarter)
- 941 13F filers
- 2 insiders bought in 180 days ($1.4M)
Well-known investors: Seth Klarman
GestorLens profileAlign Technology
ALGN- 16:30 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
G. Zachary Gund, as trustee, sole manager or co-manager and 5 related filers report a 2.5% stake (1,783,647 shares), below 5% as of September 30, 2026.
Filed by: Gund G Zachary
Neptune Insurance Holdings
NP- 16:29 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Matthew Duffy (officer, director) may sell up to 86,000 shares (~$2.4 million, 0.09% of shares outstanding) on or about November 10, 2026.
Hinge Health
HNGE- 16:27 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: James Budge (officer) may sell up to 35,907 shares (~$4.4 million, 0.05% of shares outstanding) on or about November 10, 2026.
Palantir Technologies
PLTR- 16:26 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Shyam Sankar (officer) may sell up to 300,000 shares (~$50.8 million) on or about November 10, 2026.
Everpure
P3 filings- 16:26 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Charles Giancarlo (director, officer) may sell up to 70,000 shares (~$7.2 million) on or about November 10, 2026.
- 16:24 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: the RWC Trust U/a DTD 02/08/2011 (director, officer) may sell up to 50,000 shares (~$5.1 million) on or about November 10, 2026.
- 16:24 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: the Eec Trust U/a DTD 02/08/2011 (director, officer) may sell up to 50,000 shares (~$5.1 million) on or about November 10, 2026.
Tapestry
TPR2 filings- 16:25 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Scott A. Roe (officer) may sell up to 117,875 shares (~$16 million, 0.06% of shares outstanding) on or about November 10, 2026.
- 09:21 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.1% (10,213,254 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Assurant
AIZ2 filings- 16:25 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: the Biju Nair Declaration of Trust (officer) may sell up to 9,818 shares (~$3.1 million) on or about November 10, 2026.
- 16:24 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Ryan T Lumsden (officer) may sell up to 3,901 shares (~$1.2 million) on or about November 10, 2026.
L3harris Technologies
LHX2 filings- 16:24 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Christopher Kubasik (officer) may sell up to 20,000 shares (~$5.5 million) on or about November 10, 2026.
- 08:30 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5% (9,343,754 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Akamai Technologies
AKAM- 16:23 ETOtherSEC 8-K 8.01
Other events
Company headline: “Akamai Announces Pricing of Offering of Convertible Senior Notes”
From the company's release
Akamai Technologies, Inc. (Nasdaq: AKAM) (“Akamai”), today announced that it has priced its private offering of $1.1 billion in aggregate principal amount of 1.00% convertible senior notes due 2028 (the “2028 Notes”) and $1.1 billion in aggregate principal amount of 1.00% convertible senior notes due 2031 (the “2031 Notes” and, together with the 2028 Notes, the “notes”).
Hagerty
HGTY- 16:22 ETOtherSEC 8-K 7.01
Regulation FD disclosure
Company headline: “Secondary Offering of its Class A Common Stock”
From the company's release
Hagerty will not receive any proceeds from the sale of shares of its Class A Common Stock by the Selling Stockholder. The Selling Stockholder will bear the underwriting discount attributable to its sale of the Class A Common Stock, and Hagerty will bear the remaining expenses.
On GestorLens
- 50 13F filers
- 1 insider bought in 180 days ($99,370)
- 2 13D filings in the last year
Well-known investors: Markel Group
GestorLens profileT. Rowe Price
TROW- 16:21 ETOtherSEC 8-K 8.01
Other events
From the filing
At its meeting on November 4, 2026, T. Rowe Price Group, Inc.'s (the "Company") Executive Compensation and Management Development Committee (the "Committee") amended the T. Rowe Price Group, Inc. 2020 Long-Term Incentive Plan (the “Plan”) along with the form of the Notice of Grant under the Plan (the "Notice").
On GestorLens
- 5 concentrated managers
- 714 13F filers
Well-known investors: Markel Group
GestorLens profileArch Capital Group
ACGL- 16:21 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Maamoun Rajeh (officer) may sell up to 48,661 shares (~$5.3 million) on or about November 10, 2026.
GoPro
GPRO- 16:19 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
From the filing
On November 10, 2026, GoPro, Inc. (the “Company”) filed with the Securities and Exchange Commission a Notification of Late Filing on Form 12b-25 (the “Form 12b-25”) with respect to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.
On GestorLens
- 64 13F filers
- 1 13D filings in the last year
Well-known investors: David Einhorn
GestorLens profileHawkEye 360
HAWK- 16:19 ETLeadership changesSEC 8-K 5.02
Departure or appointment of directors or officers
Company headline: “HawkEye 360 Appoints Former CIA Director Ambassador William J. Burns to Board of Directors”
Also: Regulation FD disclosure
From the filing
On November 10, 2026, the Board of Directors (the “Board”) of HawkEye 360, Inc. (the “Company”) appointed Ambassador William J. Burns as a Board member, effective immediately.
Genpact
G- 16:18 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Piyush Mehta (officer) may sell up to 200,000 shares (~$8.6 million, 0.12% of shares outstanding) on or about November 10, 2026.
WEC Energy Group
WEC- 16:18 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Margaret C Kelsey (officer) may sell up to 18,380 shares (~$2.2 million) on or about November 10, 2026.
On GestorLens
- 4 concentrated managers (-1 this quarter)
- 790 13F filers
Well-known investors: Soros Fund
GestorLens profileFactset Research Systems
FDS- 16:18 ETOtherSEC 8-K 7.01
Regulation FD disclosure
Company headline: “FactSet Hosts Investor Day 2026”
From the company's release
“FactSet has a generational opportunity to become the world’s most trusted financial intelligence platform and create long-term shareholder value.
On GestorLens
- 4 concentrated managers (-2 this quarter)
- 452 13F filers
Well-known investors: Markel Group
GestorLens profileKeel Infrastructure
KEEL- 16:17 ETLeadership changesSEC 8-K 5.02
Departure or appointment of directors or officers
From the filing
Effective November 4, 2026, Rachel Silverstein ceased serving as EVP, General Counsel and Corporate Secretary of Keel Infrastructure Corp. (the “Company”). We appreciate Ms. Silverstein’s contributions to the success of the Company during her tenure.
On GestorLens
- 126 13F filers
- 2 insiders bought in 180 days ($525,657)
Well-known investors: Soros Fund
GestorLens profileDollar General
DG- 16:17 ETLeadership changesSEC 8-K 5.02
Departure or appointment of directors or officers
Timothy I. McGuire resigns from the board.
From the filing
On November 5, 2026, Timothy I. McGuire notified Dollar General Corporation (the “Company”) of his decision to resign from the Company’s Board of Directors for personal reasons.
On GestorLens
- 6 concentrated managers
- 684 13F filers
Well-known investors: Markel Group, Semper Augustus
GestorLens profileInvesco
IVZ- 16:17 ETOtherSEC 8-K 7.01
Regulation FD disclosure
On GestorLens
- 1 concentrated managers
- 370 13F filers
Well-known investors: Nelson Peltz
GestorLens profileCostco Wholesale
COST- 16:16 ETLeadership changesSEC 8-K 5.02
Departure or appointment of directors or officers
Helena B. Foulkes resigns from the board, effective November 7, 2026.
Company headline: “COSTCO WHOLESALE CORPORATION DECLARES $30 SPECIAL CASH DIVIDEND AND REAUTHORIZES STOCK REPURCHASE PROGRAM”
Also: Other events
From the filing
On November 7, 2026, Helena B. Foulkes notified the Board of Directors (the “Board”) of Costco Wholesale Corporation (the “Company”) of her decision to resign from the Board and all committees of the Board of which she is a member, effective November 7, 2026.
On GestorLens
- 48 concentrated managers (-2 this quarter)
- 2,814 13F filers
Well-known investors: Markel Group, Semper Augustus
GestorLens profileCore & Main
CNM- 16:16 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Company headline: “Core & Main Announces Preliminary Third-Quarter Fiscal 2026 Results, Updated Fiscal 2026 Outlook, Multiple Acquisitions and Record Share Repurchases”
From the company's release
In the third quarter, Core & Main delivered 3% sales growth amid a mixed demand environment. Preliminary Adjusted EBITDA (Non-GAAP) was affected by higher transportation costs and investments in greenfields to drive long-term growth.
On GestorLens
- 1 concentrated managers
- 196 13F filers
- 1 insider bought in 180 days ($95,103)
Well-known investors: Soros Fund
GestorLens profileVentas
VTR- 16:15 ETOtherSEC 8-K 8.01
Other events
From the filing
On November 10, 2026, Ventas Realty, Limited Partnership (“Ventas Realty”), a wholly owned subsidiary of Ventas, Inc. (the “Company”), issued and sold $500,000,000 in aggregate principal amount of its 5.500% Senior Notes due 2033 (the “Notes”) in a registered public offering pursuant to the existing registration statement of the Company and Ventas Realty on Form S-3 (File Nos. 333-277185 and 333-277185-01) filed…
On GestorLens
- 3 concentrated managers
- 530 13F filers
- 1 insider bought in 180 days ($197,025)
Steris
STE- 16:15 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Mohsen Sohi (director) may sell up to 4,893 shares (~$1.2 million) on or about November 10, 2026.
American Barrick Gold Corp
- 16:14 ETIPOsSEC S-1
IPO registration filing
Underwriters: Goldman Sachs, BofA Securities, Citigroup, RBC Capital Markets
Not listed yet: no profile.
Visa
V- 16:12 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Paul D Fabara (officer) may sell up to 3,401 shares (~$1.4 million) on or about November 10, 2026.
On GestorLens
- 86 concentrated managers (+2 this quarter)
- 2,992 13F filers
Well-known investors: Markel Group, Chris Hohn, ValueAct, Akre Capital and 4 more
GestorLens profileAAON
AAON- 16:11 ETDividends and buybacksSEC 8-K 8.01
Dividends and buybacks
Other events.
Company headline: “The Aaon Group Announces Quarterly Cash Dividend”
From the company's release
AAON, Inc. (NASDAQ: AAON), doing business as The Aaon Group, a leader in high-performing, energy-efficient HVAC solutions that bring long-term value to customers and owners, today announced that its Board of Directors has declared the Company’s next regular quarterly cash dividend of $0.10 per share (or $0.40 annually), payable on December 17, 2026…
On GestorLens
- 1 concentrated managers (-1 this quarter)
- 207 13F filers
- 2 insiders bought in 180 days ($109,584)
Well-known investors: Giverny Capital
GestorLens profileeBay
EBAY- 16:10 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Julie Anne Loeger (officer) may sell up to 41,649 shares (~$5.1 million) on or about November 10, 2026.
On GestorLens
- 6 concentrated managers (-1 this quarter)
- 723 13F filers
- 1 13D filings in the last year
Chevron
CVX- 16:10 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Mark A Nelson (officer) may sell up to 112,000 shares (~$23.6 million) on or about November 10, 2026.
On GestorLens
- 45 concentrated managers (-1 this quarter)
- 2,881 13F filers
Well-known investors: Berkshire Hathaway, Semper Augustus
GestorLens profileLumentum Holdings
LITE3 filings- 16:07 ETMergers and tender offersSEC 425
Communication about a merger or acquisition
Marvell Technology filed a communication about its deal with Lumentum Holdings.
From the filing
On November 2, 2026, Matt Murphy, CEO of Marvell Technology, Inc. (“Marvell”), and Michael Hurlston, CEO of Lumentum Holdings Inc. (“Lumentum”), participated in an interview on “Fox Business: The Claman Countdown.”
- 16:05 ETMergers and tender offersSEC 425
Communication about a merger or acquisition
Marvell Technology filed a communication about its deal with Lumentum Holdings.
From the filing
On November 2, 2026, Matt Murphy, CEO of Marvell Technology, Inc. (“Marvell”), and Michael Hurlston, CEO of Lumentum Holdings Inc. (“Lumentum”), participated in an interview on “CNBC; Squawk on the Street.”
- 16:03 ETMergers and tender offersSEC 425
Communication about a merger or acquisition
Marvell Technology filed a communication about its deal with Lumentum Holdings.
From the filing
The following communication was made available to employees of Marvell via email by Matt Murphy, Chairman and Chief Executive Officer of Marvell Technology, Inc. (“Marvell”) on November 10, 2026.
Capital One Financial
COF- 16:05 ETOtherSEC 8-K 7.01
Regulation FD disclosure
On GestorLens
- 9 concentrated managers
- 1,241 13F filers
Well-known investors: Markel Group, Dan Loeb, Soros Fund, Viking Global and 1 more
GestorLens profileNorthern Trust
NTRS- 16:05 ETOtherSEC 8-K 8.01
Other events
From the filing
On November 10, 2026, Northern Trust Corporation (the “Company”) issued $1,000,000,000 of its 5.300% Senior Notes due 2031 (the “2031 Notes”) and $1,000,000,000 of its 5.700% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an underwriting agreement, dated as of November 5, 2026, by and among the Company, BofA Securities, Inc., Citigroup Global Markets Inc.…
On GestorLens
- 7 concentrated managers
- 579 13F filers
- 1 insider bought in 180 days ($85,691)
CoreWeave
CRWV- 16:05 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 (ended September 30, 2026) results.
Company headline: “CoreWeave Reports Strong Third Quarter 2026 Results”
From the company's release
"This was a breakout quarter for CoreWeave, with revenue increasing by more than $1 billion sequentially and adjusted operating margins reaching double digits a quarter ahead of plan," said Michael Intrator, co-founder, chairman and chief executive officer of CoreWeave.
On GestorLens
- 3 concentrated managers (+1 this quarter)
- 544 13F filers
Well-known investors: David Tepper, Soros Fund
GestorLens profileIndependence Realty Trust
IRT- 16:05 ETOtherSEC 8-K 7.01
Regulation FD disclosure
Vote results of the special shareholder meeting held on November 10, 2026.
Company headline: “Independence Realty Trust Stockholders and Centerspace Shareholders Approve Merger”
Also: Shareholder vote results
From the filing
Independence Realty Trust, Inc. (the "Company") held a special meeting of stockholders on November 10, 2026 (the "Special Meeting").
Sea
SE- 16:05 ETEarningsSEC 6-K
Foreign issuer report
Q3 2026 (ended September 30, 2026) results.
Company headline: “Sea Limited Reports Third Quarter 2026 Results”
From the company's release
In the third quarter of 2026, Sea’s GAAP revenue was US$8.6 billion, up 43.4% year-on-year. The Company also achieved gross profit of US$3.9 billion, up 51.4% year-on-year, and net income of US$502.5 million, up 34.0% year-on-year.
On GestorLens
- 9 concentrated managers (+2 this quarter)
- 377 13F filers
- 1 13D filings in the last year
Well-known investors: Tiger Global, Stanley Druckenmiller, Howard Marks, Viking Global and 1 more
GestorLens profileCavco Industries
CVCO- 16:04 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Brian Cira (officer) may sell up to 2,382 shares (~$1.6 million) on or about November 10, 2026.
Molina Healthcare
MOH- 16:03 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Jeff D Barlow (officer) may sell up to 8,000 shares (~$1.6 million) on or about November 10, 2026.
On GestorLens
- 2 concentrated managers (-1 this quarter)
- 301 13F filers
Well-known investors: Michael Burry, Seth Klarman
GestorLens profileDanaher
DHR- 16:03 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Georgeann Couchara may sell up to 23,010 shares (~$5.4 million) on or about November 10, 2026.
On GestorLens
- 22 concentrated managers (-1 this quarter)
- 1,300 13F filers
Well-known investors: Dan Loeb, Tiger Global, Stanley Druckenmiller, Gates Foundation Trust
GestorLens profileEastman Chemical
EMN- 16:03 ETInsider buyingSEC Form 4 (P)
Open-market purchase by an insider
Julie A. McAlindon (SVP, Regions & Chf SupChn Ofcr) bought 2,451 shares for $159,989 (avg. $65.27).
On GestorLens
- 1 concentrated managers
- 360 13F filers
Well-known investors: Markel Group
GestorLens profileHCA Healthcare
HCA- 16:02 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Erica Rossitto (officer) may sell up to 3,500 shares (~$1.8 million) on or about November 10, 2026.
On GestorLens
- 8 concentrated managers
- 771 13F filers
- 1 13D filings in the last year
Well-known investors: Markel Group
GestorLens profileHess Midstream
HESM- 15:51 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Invesco updated its stake: 6.5% (8,345,361 shares) (passive, 13G) as of September 30, 2026.
Filed by: Invesco Ltd.
Globe Life
GL- 15:46 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Invesco updated its stake: 6.5% (5,020,088 shares) (passive, 13G) as of September 30, 2026.
Filed by: Invesco Ltd.
Element Solutions
ESI- 15:38 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Invesco reports a 1.6% stake (4,015,209 shares), below 5% as of September 30, 2026.
Filed by: Invesco Ltd.
MetLife
MET- 15:34 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Michel Khalaf (officer, director) may sell up to 187,425 shares (~$19.1 million) on or about November 10, 2026.
United Airlines Holdings
UAL- 15:17 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: J Scott Kirby (officer, director) may sell up to 90,367 shares (~$10.9 million) on or about November 10, 2026.
On GestorLens
- 2 concentrated managers (-1 this quarter)
- 546 13F filers
Well-known investors: Stanley Druckenmiller
GestorLens profileCognizant Technology Solutions
CTSH- 15:16 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Invesco reports a 3.2% stake (14,622,570 shares), below 5% as of September 30, 2026.
Filed by: Invesco Ltd.
On GestorLens
- 4 concentrated managers
- 530 13F filers
- 1 insider bought in 180 days ($209,768)
Well-known investors: Semper Augustus
GestorLens profileCognex
CGNX- 15:12 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Invesco reported a stake: 5.1% (8,517,786 shares) (passive, 13G) as of September 30, 2026.
Filed by: Invesco Ltd.
Globus Medical
GMED- 15:11 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: James R Tobin (director) may sell up to 41,666 shares (~$3.1 million) on or about November 10, 2026.
The Clorox
CLX- 15:08 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Invesco reported a stake: 5.2% (6,294,677 shares) (passive, 13G) as of September 30, 2026.
Filed by: Invesco Ltd.
On GestorLens
- 4 concentrated managers (+1 this quarter)
- 580 13F filers
- 1 insider bought in 180 days ($400,251)
Well-known investors: Terry Smith
GestorLens profileCredicorp
BAP- 15:05 ETEarningsSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “Analysis of 3Q26 Consolidated Results”
From the company's release
Credicorp Ltd. Reports Financial and Operating Results for 3Q26 3Q26 ROE of 19.9%, supported by loan growth, healthy asset quality and diversified revenues; FY26 guidance of ~19.5% and the medium-term expectation of ~22% reaffirmed.
Charles River Laboratories International
CRL- 15:03 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Invesco reports a 3.9% stake (1,852,539 shares), below 5% as of September 30, 2026.
Filed by: Invesco Ltd.
Allstate
ALL- 14:45 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Thomas J Wilson (officer, director) may sell up to 130,917 shares (~$34 million, 0.05% of shares outstanding) on or about November 10, 2026.
On GestorLens
- 2 concentrated managers
- 1,083 13F filers
Well-known investors: Markel Group
GestorLens profileAcadian Asset Management
AAMI- 14:34 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Invesco reported a stake: 5.6% (1,989,483 shares) (passive, 13G) as of September 30, 2026.
Filed by: Invesco Ltd.
On GestorLens
- 138 13F filers
- 1 13D filings in the last year
Well-known investors: Soros Fund
GestorLens profileSteel Dynamics
STLD- 14:12 ETDividends and buybacksSEC 8-K 8.01
Dividend announcement
Quarterly dividend of $0.53 per share, payable January 8, 2027 to shareholders of record on December 31, 2026.
Company headline: “Steel Dynamics Announces Additional $3.0 Billion Share Repurchase Authorization and Fourth Quarter 2026 Cash Dividend”
From the company's release
The company's board of directors also declared a quarterly cash dividend of $0.53 per common share. The dividend is payable to shareholders of record at the close of business on December 31, 2026, and is payable on or about January 8, 2027.
Willis Towers Watson
WTW- 14:06 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
First Eagle Investment Management reported a stake: 5% (4,689,660 shares) (passive, 13G) as of September 30, 2026.
Filed by: First Eagle Investment Management, LLC
Floor & Decor Holdings
FND- 13:07 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Ersan Sayman (officer) may sell up to 21,428 shares (~$1.1 million) on or about November 10, 2026.
On GestorLens
- 2 concentrated managers (-1 this quarter)
- 211 13F filers
Well-known investors: Giverny Capital
GestorLens profileReinsurance Group of America
RGA- 13:05 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Jonathan Porter (officer) may sell up to 3,852 shares (~$1.0 million) on or about November 10, 2026.
Broadridge Financial Solutions
BR2 filings- 12:53 ETDividends and buybacksSEC 8-K 8.01
Dividend announcement
Quarterly dividend of $1.09 per share, payable January 11, 2027 to shareholders of record on December 10, 2026.
Company headline: “Broadridge Declares Quarterly Dividend of $1.09 Per Share”
Also: Amendments to bylaws or fiscal year
From the filing
On November 10, 2026, Broadridge Financial Solutions, Inc. (the "Company") issued a press release announcing that its Board of Directors has declared a quarterly cash dividend of $1.09 per share. The dividend is payable on January 11, 2027 to stockholders of record at the close of business on December 10, 2026.
- 06:46 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.1% (5,766,233 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
BlackRock
BLK- 12:04 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Rachel Lord (officer) may sell up to 7,000 shares (~$8.5 million) on or about November 9, 2026.
On GestorLens
- 12 concentrated managers (+1 this quarter)
- 1,524 13F filers
Well-known investors: Markel Group, ValueAct
GestorLens profileChurch & Dwight
CHD- 10:45 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Surabhi Pokhriyal (officer) may sell up to 21,970 shares (~$2.4 million) on or about November 10, 2026.
On GestorLens
- 5 concentrated managers
- 594 13F filers
Well-known investors: Terry Smith
GestorLens profileKLA
KLAC- 10:09 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Richard P Wallace (officer, director) may sell up to 72,014 shares (~$10.7 million) on or about November 10, 2026.
Trimble
TRMB- 09:24 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4% stake (9,301,634 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
TKO Group Holdings
TKO- 09:21 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5% (3,667,379 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 4 concentrated managers
- 306 13F filers
- 1 insider bought in 180 days ($987,797)
- 1 13D filings in the last year
Well-known investors: Soros Fund
GestorLens profileSkyworks Solutions
SWKS- 09:16 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.6% stake (6,855,096 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
RPM International
RPM- 09:12 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.6% stake (5,836,328 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Reddit
RDDT- 09:08 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6.4% (9,324,459 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 3 concentrated managers
- 474 13F filers
- 1 13D filings in the last year
Well-known investors: Tiger Global, Coatue, Viking Global, Stanley Druckenmiller and 1 more
GestorLens profileQuest Diagnostics
DGX- 09:06 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5% (5,563,421 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Icon
ICLR- 09:03 ETOtherSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “ICON to Participate at Upcoming Investor Conferences”
From the company's release
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that Mr. Barry Balfe, CEO of ICON plc, and Mr. Nigel Clerkin, CFO of ICON plc, will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026 at 12:30pm GMT and Mr. Barry Balfe, CEO of ICON plc, will participate at the 9th Annual Evercore Healthcare Conference on Tuesday, December 1…
Qualcomm
QCOM- 09:01 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Filed by: STATE STREET CORP
On GestorLens
- 20 concentrated managers (+1 this quarter)
- 1,925 13F filers
Well-known investors: Viking Global, David Tepper, Coatue
GestorLens profileAllison Transmission Holdings
ALSN- 09:00 ETOtherSEC 8-K 7.01
Regulation FD disclosure
Prudential Financial
PRU- 09:00 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Filed by: STATE STREET CORP
Veradermics
MANE- 08:54 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “Veradermics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress”
From the company's release
Among participants in the VDPHL01 continued group who received VDPHL01 8.5 mg twice (BID) or once (QD) daily for twelve months, participants achieved a mean increase in non-vellus target area hair count (TAHC) of 43.9 hairs/cm² (BID) and 29.7 hairs/cm² (QD) at Month 12.
On GestorLens
- 5 concentrated managers
- 164 13F filers
- 4 13D filings in the last year
Well-known investors: Viking Global
GestorLens profileOneok
OKE- 08:53 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6.6% (41,513,057 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Omnicom Group
OMC- 08:52 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 7.4% (20,353,572 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Oceaneering International
OII- 08:51 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.8% stake (4,795,888 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Novavax
NVAX- 08:50 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.4% (8,827,707 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 3 concentrated managers (+1 this quarter)
- 267 13F filers
- 1 13D filings in the last year
Well-known investors: Coatue
GestorLens profileNews
NWSA- 08:49 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 7.2% (26,047,836 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 8 concentrated managers
- 636 13F filers
Well-known investors: Starboard Value
GestorLens profileNetscout Systems
NTCT- 08:48 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.9% stake (3,563,952 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Nektar Therapeutics
NKTR- 08:44 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.2% (1,772,302 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Mosaic
MOS- 08:43 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6.2% (19,698,380 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Medtronic
MDT- 08:41 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.2% (66,055,969 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Bitdeer Technologies Group
BTDR- 08:38 ETEarningsSEC 6-K
Foreign issuer report
Q3 2026 (ended September 30, 2026) results.
Company headline: “Bitdeer Reports Unaudited Third Quarter 2026 Results: Record Revenue of US$320.7 Million; Adjusted EBITDA Up 173% to US$69.6 Million AI Cloud revenue backlog grows…”
From the company's release
US$30.1 million, including a non-cash loss of US$54.6 million from the change in fair value of the digital assets loan.
On GestorLens
- 10 concentrated managers (+6 this quarter)
- 237 13F filers
- 2 insiders bought in 180 days ($447,000)
- 2 13D filings in the last year
Well-known investors: Stanley Druckenmiller, Lone Pine
GestorLens profileMcEwen
MUX- 08:38 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.4% (3,293,188 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 3 concentrated managers
- 170 13F filers
- 1 insider bought in 180 days ($18,360)
Materion
MTRN- 08:37 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street and 1 related filer reported a stake: 7.7% (1,603,883 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 5 concentrated managers (+2 this quarter)
- 404 13F filers
Well-known investors: Soros Fund
GestorLens profileMartin Marietta Materials
MLM- 08:34 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.6% stake (3,275,168 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 26 concentrated managers (+1 this quarter)
- 1,076 13F filers
- 1 13D filings in the last year
Well-known investors: Chris Hohn
GestorLens profileMannKind
MNKD- 08:33 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (15,096,712 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Magnolia Oil & Gas
MGY- 08:33 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (12,677,038 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 2 concentrated managers
- 412 13F filers
- 3 insiders bought in 180 days ($326,956)
Lexeo Therapeutics
LXEO- 08:31 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.4% stake (3,594,095 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
FLEX
FLEX- 08:30 ETOtherSEC 8-K 7.01
Regulation FD disclosure
From the company's release
O U R C O M M I T M E N T Safety First Our success starts with protecting our people. A safe workplace enables our people to thrive, our operations to perform, and a brighter future for our customers, communities and the planet.
On GestorLens
- 13 concentrated managers (+6 this quarter)
- 1,126 13F filers
Well-known investors: Dan Loeb
GestorLens profileKratos Defense & Security Solutions
KTOS- 08:29 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.2% (9,707,708 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Karman Holdings
KRMN- 08:27 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6% (7,889,482 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 2 concentrated managers
- 361 13F filers
- 3 insiders bought in 180 days ($1M)
Nova
NVMI- 08:26 ETPlanned insider salesSEC Form 144
Notice of proposed sale (Form 144)
Notice of proposed sale: Rani (Raanan) Cohen (director) may sell up to 3,121 shares (~$1.0 million) on or about November 10, 2026.
LCI Industries
LCII3 filings- 08:23 ETMergers and tender offersSEC 425
Communication about a merger or acquisition
LCI Industries filed a communication about its merger.
From the filing
On November 10, 2026, Johnny Sirpilla, the Interim Chief Executive Officer of LCI Industries (the “Company”), sent the following message to all of the Company’s employees via email in connection with the proposed transaction between the Company and Patrick Industries, Inc. (“Patrick”):
- 07:34 ETMergers and tender offersSEC 425
Communication about a merger or acquisition
- 07:32 ETOtherSEC 8-K 8.01
Other events
Company headline: “LCI Board Determines that Revised, Unsolicited, Non-Binding Proposal from Monomoy Capital”
From the company's release
LCI Industries Reiterates Support for Merger with Patrick ELKHART, Ind. - LCI Industries (NYSE: LCII) (“LCI”) today announced that its Board of Directors (the “Board”), in consultation with its outside financial and legal advisors, has unanimously determined that a revised, unsolicited…
Iovance Biotherapeutics
IOVA- 08:22 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.8% stake (21,695,003 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Intuitive Machines
LUNR- 08:21 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports 5% (8,656,543 shares), 5% or less as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 1 concentrated managers (+1 this quarter)
- 325 13F filers
- 1 13D filings in the last year
International Paper
IP- 08:20 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6.5% (34,166,190 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Intellia Therapeutics
NTLA- 08:19 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.6% (7,809,060 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Indie Semiconductor
INDI- 08:14 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.9% (12,902,835 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Corbus Pharmaceuticals Holdings
CRBP- 08:08 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Company headline: “Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate Update…”
Also: Regulation FD disclosure
From the company's release
The Company reported a net loss of approximately $37.8 million, or a net loss per basic and diluted share of $1.81, for the three months ended September 30, 2026, compared to a net loss of approximately $23.3 million, or a net loss per basic and diluted share of $1.90, for the three months ended September 30, 2025.
On GestorLens
- 4 concentrated managers (+1 this quarter)
- 107 13F filers
- 1 insider bought in 180 days ($126,243)
Coursera
COUR- 08:06 ETOtherSEC 8-K 2.05
Exit or restructuring costs
Restructuring plan: about 10% workforce reduction; estimated costs of $14 million to $17 million.
From the filing
The workforce reduction plan is expected to result in the termination of approximately 10% of the Company's global workforce.
On GestorLens
- 3 concentrated managers (-1 this quarter)
- 251 13F filers
- 1 13D filings in the last year
Sigma Lithium
SGML- 08:05 ETOtherSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “SIGMA LITHIUM TO RELEASE 3Q 26 EARNINGS RESULTS ON NOVEMBER 13; WATCH CEO ANA CABRAL ON SIGMA’S NEW CHAPTER OF GROWTH”
From the company's release
The Company will hold a conference call to discuss its third quarter 2026 earnings results shortly after, on Friday, November 13, 2026, at 7:00 a.m. EST. Access to the call will be available via webcast.
Tyra Biosciences
TYRA- 08:03 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent Highlights”
From the company's release
Dr. Harris continued, “With a strengthened balance sheet following our $400 million financing, TYRA is entering its next phase of growth from a position of strength.
On GestorLens
- 10 concentrated managers (-3 this quarter)
- 168 13F filers
- 1 insider bought in 180 days ($20,001)
- 1 13D filings in the last year
Coya Therapeutics
COYA- 08:02 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Results for the quarter ended September 30, 2026.
Company headline: “Coya Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update”
From the company's release
As of September 30, 2026, Coya had cash and cash equivalents of $35.8 million, sufficient to fund operations, as currently planned, past the Phase 2/3 ALSTARS topline data readout and into the second half of 2027.
On GestorLens
- 3 concentrated managers
- 54 13F filers
Well-known investors: David Einhorn
GestorLens profilePepgen
PEPG- 08:00 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “PepGen Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights”
Also: Regulation FD disclosure; Other events
From the company's release
Topline data from the 10 mg/kg dose cohort demonstrated a mean splicing correction of 46.5%, the highest reported to date in a multiple dose study.
On GestorLens
- 6 concentrated managers (+2 this quarter)
- 70 13F filers
Well-known investors: Viking Global
GestorLens profileAST Spacemobile
ASTS- 08:00 ETOtherSEC 8-K 7.01
Regulation FD disclosure
Company headline: “Rakuten and AST SpaceMobile Establish “Rakuten AST”…”
From the company's release
Rakuten Group, Inc. and AST SpaceMobile, Inc. (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, agreed to establish Rakuten AST, Inc. on November 6, 2026 (Japan Standard Time)*1.
On GestorLens
- 4 concentrated managers (+1 this quarter)
- 757 13F filers
- 1 insider bought in 180 days ($619,200)
- 4 13D filings in the last year
PMV Pharmaceuticals
PMVP- 08:00 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “PMV Pharmaceuticals Reports Third Quarter 2026 Financial Results and Corporate Highlights”
From the company's release
“We achieved significant milestones during the third quarter across the organization,” said David Mack, Ph.D., President and Chief Executive Officer of PMV Pharma.
Highwoods Properties
HIW- 07:58 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 7.1% (7,802,704 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Hecla Mining
HL- 07:57 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (31,604,111 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Hancock Whitney
HWC- 07:56 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.9% stake (3,955,751 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Grail
GRAL- 07:49 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.5% stake (2,015,422 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Glacier Bancorp
GBCI- 07:48 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.8% stake (6,254,871 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 1 concentrated managers
- 436 13F filers
- 1 insider bought in 180 days ($105,840)
CRH Public
CRH- 07:42 ETInsider buyingSEC Form 4 (P)
Open-market purchase by an insider
Richard H Fearon (director) bought 6,000 shares for $569,700 (avg. $94.95).
On GestorLens
- 26 concentrated managers (+2 this quarter)
- 1,028 13F filers
- 1 insider bought in 180 days ($189,260)
Well-known investors: Dan Loeb, Stanley Druckenmiller, Soros Fund
GestorLens profileKalaris Therapeutics
KLRS- 07:42 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update”
From the company's release
Cash, Cash Equivalents and Marketable Securities: As of September 30, 2026, Kalaris had cash, cash equivalents and marketable securities of $82.9 million, compared with cash, cash equivalents and marketable securities of $118.0 million as of December 31, 2025.
Mirum Pharmaceuticals
MIRM- 07:41 ETOtherSEC 8-K 8.01
Other events
From the filing
On November 10, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) announced that the primary endpoint was met in the Phase 3 AZURE-4 study evaluating brelovitug, an investigational fully human monoclonal antibody that binds to hepatitis B surface antigen, for the treatment of chronic hepatitis delta virus (“HDV”).
On GestorLens
- 16 concentrated managers (-1 this quarter)
- 327 13F filers
- 1 13D filings in the last year
MasterCraft Boat Holdings
MCFT- 07:36 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Company headline: “MasterCraft Boat Holdings, Inc. Reports Results for the First Three Months of Its Transition Period”
From the company's release
On May 15, 2026, the Company completed the merger with Marine Products (“Marine Products Transaction”). As a result, the Company recognized incremental net sales of $59.3 million within the Recreation and Sport Fishing segment during the first three months of the Transition Period (as defined below) compared to the first three months of fiscal 2026.
On GestorLens
- 3 concentrated managers
- 155 13F filers
- 3 insiders bought in 180 days ($148,719)
- 2 13D filings in the last year
Entegris
ENTG- 07:31 ETDividends and buybacksSEC 8-K 8.01
Share buyback
New share buyback of up to $500 million.
Company headline: “ENTEGRIS DETAILS GROWTH STRATEGY AND LONG-TERM FINANCIAL MODEL AT 2026 CAPITAL MARKETS DAY”
Also: Regulation FD disclosure
From the filing
On November 8, 2026, the Board of Directors of the Company (the "Board") authorized a share repurchase program under which the Company may repurchase up to $500 million of its outstanding common stock.
On GestorLens
- 13 concentrated managers (+4 this quarter)
- 750 13F filers
Well-known investors: Stanley Druckenmiller
GestorLens profileGeron
GERN- 07:31 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports 5% (31,896,515 shares), 5% or less as of September 30, 2026.
Filed by: STATE STREET CORP
Frontdoor
FTDR- 07:30 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (3,229,939 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Fox
FOXA2 filings- 07:29 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.9% stake (10,723,159 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
- 07:28 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 7.3% (14,739,582 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 7 concentrated managers (+2 this quarter)
- 748 13F filers
- 1 insider bought in 180 days ($10.3M)
Well-known investors: Stanley Druckenmiller
GestorLens profileAutolus Therapeutics
AUTL- 07:25 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 (ended September 30, 2026) results.
Also: Regulation FD disclosure
From the company's release
Autolus Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates November 10, 2026 at 7:00 AM EST Company reports AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $41.2 million, an increase of 95% year-over-year; now expects full-year 2026 AUCATZYL net product revenue to be at or exceeding upper end of $150 million from prior guidance Gross margin increased to 57%…
FMC
FMC- 07:24 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.2% stake (6,489,128 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Commercial Metals
CMC- 07:24 ETLeadership changesSEC 8-K 5.02
Departure or appointment of directors or officers
Company headline: “CMC Announces CFO Retirement and Succession Plan; Appoints Kenji Hashimoto as Deputy CFO”
Also: Regulation FD disclosure
From the filing
On November 6, 2026, Paul J. Lawrence notified Commercial Metals Company (“CMC” or the “Company”) of his decision to retire from the role of the Company’s Senior Vice President and Chief Financial Officer, effective January 15, 2027.
On GestorLens
- 1 concentrated managers
- 524 13F filers
- 2 insiders bought in 180 days ($604,468)
Fidelity National Information Services
FIS- 07:24 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.4% (27,828,330 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
FB Financial
FBK- 07:23 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.4% (2,679,079 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 4 concentrated managers (-2 this quarter)
- 295 13F filers
- 1 insider bought in 180 days ($1.5M)
- 2 13D filings in the last year
Exxon Mobil
XOM- 07:22 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.1% (212,943,706 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 71 concentrated managers (-9 this quarter)
- 3,901 13F filers
Well-known investors: Semper Augustus
GestorLens profileExpedia Group
EXPE- 07:21 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5% (5,745,071 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
EPR Properties
EPR- 07:19 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.1% (3,870,076 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
EchoStar
ECHO- 07:17 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.7% (9,040,863 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 20 concentrated managers (-7 this quarter)
- 703 13F filers
- 1 13D filings in the last year
Well-known investors: Carl Icahn
GestorLens profileEastern Bankshares
EBC- 07:17 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.9% stake (11,091,105 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Eagle Bancorp
EGBN- 07:15 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.9% stake (1,486,413 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Dupont De Nemours
DD- 07:13 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.6% stake (6,158,254 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Dollar Tree
DLTR- 07:11 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.2% (9,753,063 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 5 concentrated managers
- 868 13F filers
- 1 13D filings in the last year
Well-known investors: Semper Augustus
GestorLens profileLegend Biotech
LEGN- 07:11 ETEarningsSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights”
From the company's release
Median overall survival was not reached at the time of analysis, and 69.2% of patients were alive at five years.
Scholar Rock Holding
SRRK- 07:10 ETEarningsSEC 8-K 1.01
Entry into a material agreement
Q3 2026 results: loss per share of $0.81.
Company headline: “Scholar Rock Reports Third Quarter 2026 Financial Results and Recent Business Highlights”
Also: Results of operations and financial condition; Regulation FD disclosure
From the company's release
Net loss per common share was $0.81 for the quarter ended September 30, 2026, compared to $0.90 per common share for the quarter ended September 30, 2025.
On GestorLens
- 10 concentrated managers (-1 this quarter)
- 308 13F filers
- 1 insider bought in 180 days ($12M)
Dexcom
DXCM- 07:08 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5% (18,917,265 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Hemab Therapeutics Holdings
COAG- 07:08 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results: loss per share of $0.58.
Company headline: “Hemab Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update”
From the company's release
Net Loss: Net loss was $27.3 million, or $0.58 per share, for the three months ended September 30, 2026, compared to a net loss of $17.1 million, or $18.04 per share, for the three months ended September 30, 2025.
On GestorLens
- 5 concentrated managers (+4 this quarter)
- 56 13F filers
- 1 insider bought in 180 days ($2M)
- 1 13D filings in the last year
Well-known investors: Soros Fund
GestorLens profileDelek US Holdings
DK- 07:07 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6.3% (3,874,849 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Dakota Gold
DC- 07:06 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.3% stake (5,827,886 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 3 concentrated managers
- 181 13F filers
- 1 insider bought in 180 days ($100,358)
Cullinan Therapeutics
CGEM2 filings- 07:06 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results”
From the company's release
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results CLN-978 (CD19 TCE) multi-dose regimen data in SLE, RA, and Sjögren’s disease will be shared in December Velinotamig (BCMA TCE) data presented at ACR Convergence 2026; global Phase 1/2 study in autoimmune cytopenias initiated CLN-049 (FLT3 TCE) potentially registrational Phase 2 study in R/R AML underway…
- 07:00 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4% stake (2,604,105 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Sionna Therapeutics
SION- 07:05 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “Sionna Therapeutics Reports Third Quarter 2026 Financial Results”
From the company's release
Implemented Workforce Reduction and Cost-Saving Measures: In September 2026, following a comprehensive review of its operations, Sionna implemented a workforce reduction of approximately 46% and other cost-saving measures to focus resources on advancing SION-451 + SION-2222 and extend its operating runway.
On GestorLens
- 11 concentrated managers (+3 this quarter)
- 146 13F filers
- 2 13D filings in the last year
Well-known investors: Viking Global
GestorLens profileOlema Pharmaceuticals
OLMA- 07:05 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 (ended September 30, 2026) results.
Company headline: “Olema Oncology Reports Third Quarter 2026 Financial and Operating Results”
From the company's release
Cash, cash equivalents, and marketable securities as of September 30, 2026, were $413.8 million.
On GestorLens
- 10 concentrated managers (-2 this quarter)
- 183 13F filers
- 1 13D filings in the last year
Well-known investors: Stanley Druckenmiller
GestorLens profileCytomX Therapeutics
CTMX- 07:04 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.1% stake (9,025,855 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Ovid Therapeutics
OVID- 07:03 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Company headline: “Ovid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results”
From the company's release
Potential monetization of soticlestat interests: As previously announced, Ovid and Takeda assigned global rights in soticlestat to a new company launched by Perceptive Advisors.
Cytokinetics
CYTK- 07:03 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.1% (7,143,229 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Cummins
CMI- 07:01 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports 5% (6,836,104 shares), 5% or less as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 19 concentrated managers (-1 this quarter)
- 2,110 13F filers
Well-known investors: Semper Augustus
GestorLens profileOpus Genetics
IRD- 07:01 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “Opus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update”
From the company's release
Opus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update OPGx-BEST1 Cohort 2 Dosing Complete and Data Expected in Q1 2027 OPGx-LCA5 Registrational Phase 3 Trial Fully Enrolled with Initiation of Dosing Expected in Q4 2026 FDA Clearance of IND for OPGx-RDH12…
D-Wave Quantum
QBTS- 07:01 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results: revenue of $4.5 million; loss per share of $0.13.
Company headline: “D-Wave Reports Third Quarter 2026 Results”
From the company's release
Revenue for the third quarter of 2026 was $4.5 million, up 21% year over year.
BioNTech
BNTX- 07:01 ETOtherSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “BioNTech to Acquire US FDA Priority Review Voucher”
From the company's release
BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that it has entered into an agreement to acquire a US Food and Drug Administration (“FDA”) Priority Review Voucher (“PRV”) from Scholar Rock, Inc. (Nasdaq: SRRK, “Scholar Rock”) for a total cash consideration of $205 million.
Enova International
ENVA- 07:01 ETDividends and buybacksSEC 8-K 8.01
Share buyback
New share buyback of up to $500 million.
Company headline: “ENOVA ANNOUNCES NEW $500 MILLION SHARE REPURCHASE PROGRAM”
From the filing
On November 10, 2026, Enova International, Inc. (the "Company") announced that its Board of Directors had authorized a share repurchase program for up to $500 million of the Company's outstanding common stock.
Liquidia
LQDA- 07:00 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Also: Other events
From the company's release
October 2026, the daily referral rate was more than 75% of the daily referral rate for the third quarter.
On GestorLens
- 7 concentrated managers (-1 this quarter)
- 336 13F filers
- 1 insider bought in 180 days ($317,894)
Janus International Group
JBI- 07:00 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results: revenue of $213.1 million; loss per share of $0.10.
Company headline: “JANUS INTERNATIONAL GROUP REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS”
Also: Regulation FD disclosure
From the company's release
Revenues of $213.1 million, down 2.8% year-over-year.
Cullen/Frost Bankers
CFR- 06:59 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (2,930,133 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Crispr Therapeutics
CRSP- 06:58 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.2% (4,994,047 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Corvus Pharmaceuticals
CRVS- 06:57 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4% stake (3,331,535 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 3 concentrated managers (-3 this quarter)
- 172 13F filers
- 2 insiders bought in 180 days ($333,654)
- 2 13D filings in the last year
Compass Therapeutics
CMPX- 06:55 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.3% stake (7,737,938 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 5 concentrated managers (-6 this quarter)
- 215 13F filers
- 1 insider bought in 180 days ($21,250)
Commerce Bancshares
CBSH- 06:54 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (6,739,385 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Cogent Communications Holdings
CCOI- 06:52 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 3.4% stake (1,756,368 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Cisco Systems
CSCO- 06:51 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports 5% (196,095,068 shares), 5% or less as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 59 concentrated managers (+7 this quarter)
- 4,103 13F filers
Well-known investors: Markel Group
GestorLens profileGFL Environmental
GFL- 06:50 ETOtherSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “GFL Environmental Concludes Review of Unsolicited Inbound Proposals; Board Unanimously Reaffirms Strategy to Remain Public”
From the company's release
GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”) today confirmed that a Special Committee of the Board of Directors (the “Board”) has concluded its previously announced process to review unsolicited proposals to acquire the Company and take it private.
On GestorLens
- 6 concentrated managers (+2 this quarter)
- 327 13F filers
Well-known investors: Soros Fund
GestorLens profileCarlisle Companies
CSL- 06:49 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Filed by: STATE STREET CORP
Caredx
CDNA- 06:48 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
Filed by: STATE STREET CORP
Brightstar Lottery
BRSL- 06:43 ETEarningsSEC 6-K
Foreign issuer report
Q3 2026 (ended September 30, 2026) results.
Company headline: “BRIGHTSTAR LOTTERY PLC REPORTS THIRD QUARTER 2026 RESULTS”
From the company's release
Diluted net income per share and Adjusted EPS from continuing operations include $43 million ($0.23 per share) of Brightstar's portion, net of tax, of service revenue amortization compared to $23 million ($0.12 per share) in 2025.
Black Hills
BKH- 06:43 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports 5% (3,806,682 shares), 5% or less as of September 30, 2026.
Filed by: STATE STREET CORP
Biogen
BIIB- 06:42 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.1% (7,570,589 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Biocryst Pharmaceuticals
BCRX- 06:38 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.8% stake (12,294,412 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Avery Dennison
AVY- 06:37 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (3,595,632 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Avalo Therapeutics
AVTX- 06:36 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.8% stake (2,563,226 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Automatic Data Processing
ADP- 06:33 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.9% stake (19,605,453 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 43 concentrated managers
- 2,299 13F filers
Well-known investors: Giverny Capital, Terry Smith
GestorLens profileAtlantic Union Bankshares
AUB- 06:33 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.9% stake (7,048,441 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
TransDigm Group
TDG- 06:32 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Fiscal Q4 (ended September 30, 2026) results: revenue of $2.99 billion; EPS of $10.33 (adjusted: $12.44).
Company headline: “TransDigm Group Reports Fiscal 2026 Fourth Quarter and Year-End Results”
From the company's release
Net sales of $2,988 million, up 23% from $2,437 million in the prior year's quarter;
On GestorLens
- 35 concentrated managers
- 1,145 13F filers
Well-known investors: Dan Loeb, Lone Pine
GestorLens profileVenture Global
VG- 06:31 ETEarningsSEC 8-K 2.02
Results of operations and financial condition
Q3 2026 results.
Company headline: “Venture Global Reports Third Quarter 2026 Results”
From the company's release
Increased Consolidated Adjusted EBITDA guidance to $10.0 - $10.3 billion1, up from $8.7 - $9.1 billion, which assumes a weighted average liquefaction fee of $21.00/MMBtu - $22.00/MMBtu for our remaining unsold cargos, in line with current forward curves.
On GestorLens
- 10 concentrated managers (+1 this quarter)
- 376 13F filers
- 1 insider bought in 180 days ($15,987)
Astronics
ATRO- 06:31 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.1% (1,840,896 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 3 concentrated managers (+1 this quarter)
- 313 13F filers
- 1 13D filings in the last year
Associated Banc-Corp
ASB- 06:30 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.4% stake (8,364,775 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Arcutis Biotherapeutics
ARQT- 06:29 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6.1% (7,718,628 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
Archer Aviation
ACHR- 06:28 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (36,379,249 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Ameris Bancorp
ABCB- 06:27 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.8% stake (3,210,262 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Altimmune
ALT- 06:26 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.3% stake (8,356,408 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 5 concentrated managers (+4 this quarter)
- 210 13F filers
- 1 insider bought in 180 days ($44,250)
Well-known investors: Viking Global
GestorLens profileAllogene Therapeutics
ALLO- 06:22 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.7% stake (16,326,197 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 5 concentrated managers (+2 this quarter)
- 207 13F filers
- 2 13D filings in the last year
Allegion
ALLE- 06:22 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.2% stake (3,581,089 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 11 concentrated managers (+3 this quarter)
- 736 13F filers
- 1 insider bought in 180 days ($26,908)
Albemarle
ALB- 06:21 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.4% (6,329,610 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
ADMA Biologics
ADMA- 06:20 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 6.1% (13,675,348 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 4 concentrated managers
- 321 13F filers
- 1 insider bought in 180 days ($150,749)
Well-known investors: Stanley Druckenmiller, Terry Smith
GestorLens profileAccenture
ACN- 06:18 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reported a stake: 5.5% (33,523,019 shares) (passive, 13G) as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 40 concentrated managers (-4 this quarter)
- 1,915 13F filers
- 2 insiders bought in 180 days ($3.2M)
Well-known investors: Markel Group
GestorLens profileAcadia Pharmaceuticals
ACAD- 06:17 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.4% stake (7,650,889 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
On GestorLens
- 6 concentrated managers (-2 this quarter)
- 351 13F filers
- 1 13D filings in the last year
Wix.com
WIX- 06:17 ETEarningsSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “Wix Reports Third Quarter 2026 Results”
From the company's release
“We believe our strategic investments in Base44 are positioning us to capture share in a rapidly expanding market – with Base44 ARR today close to $250 million.
On GestorLens
- 3 concentrated managers (-3 this quarter)
- 237 13F filers
Well-known investors: ValueAct, Soros Fund
GestorLens profileKanzhun
BZ- 06:16 ET5%+ stakesSEC Schedule 13G/A
Change in a passive 5%+ stake
Image Frame Investment (HK) and 1 related filer report a 2.2% stake (18,324,051 shares), below 5% as of September 30, 2026.
Filed by: Tencent Holdings Ltd
4D Molecular Therapeutics
FDMT- 06:16 ET5%+ stakesSEC Schedule 13G
New passive 5%+ stake
State Street reports a 4.5% stake (2,469,425 shares), below 5% as of September 30, 2026.
Filed by: STATE STREET CORP
Magnachip Semiconductor
MX- 06:15 ETInsider buyingSEC Form 4 (P)
Open-market purchase by an insider
Chae Lee (Chief Executive Officer) bought 70,000 shares for $155,360 (avg. $2.22).
On GestorLens
- 2 concentrated managers
- 77 13F filers
- 1 insider bought in 180 days ($318,600)
- 1 13D filings in the last year
Well-known investors: Howard Marks
GestorLens profileOn Holding
ONON- 06:06 ETEarningsSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “On Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2026”
From the company's release
On delivers record net sales and the highest gross profit margin in its history as it pursues its ambition to redefine what a sportswear brand can be. Third quarter net sales increase by 17.2% year-over-year, or by 17.8% on a constant currency basis, to CHF 931.4 million, surpassing CHF 900 million in a quarter for the first time, with every channel, region and category contributing strongly.
On GestorLens
- 12 concentrated managers (+2 this quarter)
- 495 13F filers
- 3 insiders bought in 180 days ($10.6M)
Well-known investors: Lone Pine, Gates Foundation Trust
GestorLens profileAtour Lifestyle Holdings
ATAT- 06:02 ETEarningsSEC 6-K
Foreign issuer report
Company announcement.
Company headline: “Atour Lifestyle Holdings Limited Reports Third Quarter 2026…”
From the company's release
As of September 30, 2026, there were 2,288 hotels with a total of 254,800 hotel rooms in operation across Atour’s hotel network, representing increases of 17.5% and 16.2% year-over-year in terms of the number of hotels and hotel rooms, respectively.
WESCO International
WCC- 06:00 ETOtherSEC 8-K 7.01
Regulation FD disclosure
Company headline: “Data Center Leadership: One Partner, Complete Lifecycle, Around the World November 10, 2026”
On GestorLens
- 10 concentrated managers
- 708 13F filers
- 1 insider bought in 180 days ($351,254)
Well-known investors: Seth Klarman
GestorLens profile
What each filing is
- Form 8-K
- The current report of a material event: the company has 4 business days to file it. Each item is a type of event; the label is the one the company chose.
- Schedule 13D
- Whoever crosses 5% of the shares intending to influence the company (board seats, a sale, a change of strategy) files a 13D within 5 business days. It is the typical activist filing. More in the glossary
- Schedule 13G
- The form filed by whoever crosses 5% of a company's shares as a passive investor, with no intent to influence it. Mostly filed by large asset managers and index funds. More in the glossary
- Form 4
- The form directors, officers and 10%+ shareholders use to report every purchase or sale of their own company's shares, within 2 business days. Only open-market purchases (code P) are shown here. More in the glossary
- Form 144
- The notice an insider or major shareholder files BEFORE selling restricted shares, when the sale exceeds 5,000 shares or $50,000 in three months. It states how many shares they plan to sell and from when: it does not confirm the sale happened (that comes later in a Form 4).
Everything comes from SEC EDGAR, the system where companies file their documents with the SEC.